Clinical and biological implications of driver mutations in myelodysplastic syndromesElli Papaemmanuil, Peter J. Campbell, Moritz Gerstung et al.|Blood|2013Cited by 1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaFrancesco Lo‐Coco, Uwe Platzbecker, Giuseppe Avvisati et al.|New England Journal of Medicine|2013Cited by 1.6k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring SideroblastsElli Papaemmanuil, Peter J. Campbell, Mario Cazzola et al.|New England Journal of Medicine|2011Cited by 1.2k
Use of Recombinant Human Erythropoietin Outside the Setting of UremiaMario Cazzola, Carlo Brugnara, F. Mercuriali|Blood|1997Cited by 262
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associationsAndrea Pellagatti, Jacqueline Boultwood, Richard N. Armstrong et al.|Blood|2018Cited by 248